- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 31.75M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $56.56M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $46.9M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $75.49M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $63.47M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $39.14M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $39.51M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $49.81M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $50.06M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $92.35M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $81M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $125.21M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $113.45M |
| Operating Income | Q1 2025 · Mar 31, 2025 | $8.27M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $1.33M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $23.25M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $9.64M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 32.24M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.34M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $6.77M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.03 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.03 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $8.31M |
| Net Income | Q1 2025 · Mar 31, 2024 | $989K |
| Revenue | Q1 2025 · Mar 31, 2024 | $26.5M |